CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Energy and Commerce Health Subcommittee Hearing on Health Care Transparency
CHA is asking Congress to ensure policies provide clear cost information for families, reflect the unique nature of pediatric care, and avoid unnecessary administrative burden.
June 23, 2026
Site Neutral Policies Negatively Impact Children
Children’s hospitals extend pediatric care close to home for patients and families.
June 22, 2026
7 Ways Pediatric Care Is Different From Adult Care
Children’s health care operates under a different set of clinical, financial, and operational realities.
June 16, 2026
